Intra-Cellular Therapies Stock Forward View - Accumulation Distribution
| ITCIDelisted Stock | USD 131.87 0.03 0.02% |
Intra-Cellular Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Intra-Cellular Therapies' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 4th of February 2026 The value of RSI of Intra-Cellular Therapies' share price is above 80 . This usually indicates that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 90
Buy Peaked
Oversold | Overbought |
Using Intra-Cellular Therapies hype-based prediction, you can estimate the value of Intra Cellular Therapies from the perspective of Intra-Cellular Therapies response to recently generated media hype and the effects of current headlines on its competitors.
Intra-Cellular Therapies after-hype prediction price | USD 131.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Intra-Cellular |
Intra-Cellular Therapies Additional Predictive Modules
Most predictive techniques to examine Intra-Cellular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intra-Cellular using various technical indicators. When you analyze Intra-Cellular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 42557.83 | 0.0027 |
| Check Intra-Cellular Therapies Volatility | Backtest Intra-Cellular Therapies | Information Ratio |
Intra-Cellular Therapies Trading Date Momentum
| On February 04 2026 Intra Cellular Therapies was traded for 131.87 at the closing time. The top price for the day was 131.98 and the lowest listed price was 131.63 . There was no trading activity during the period 0.0. Lack of trading volume on February 4, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.02% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Intra-Cellular Therapies to competition
Intra-Cellular Therapies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intra-Cellular Therapies stock to make a market-neutral strategy. Peer analysis of Intra-Cellular Therapies could also be used in its relative valuation, which is a method of valuing Intra-Cellular Therapies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Intra-Cellular Therapies Market Strength Events
Market strength indicators help investors to evaluate how Intra-Cellular Therapies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intra-Cellular Therapies shares will generate the highest return on investment. By undertsting and applying Intra-Cellular Therapies stock market strength indicators, traders can identify Intra Cellular Therapies entry and exit signals to maximize returns.
Story Coverage note for Intra-Cellular Therapies
The number of cover stories for Intra-Cellular Therapies depends on current market conditions and Intra-Cellular Therapies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intra-Cellular Therapies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intra-Cellular Therapies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Intra-Cellular Therapies Short Properties
Intra-Cellular Therapies' future price predictability will typically decrease when Intra-Cellular Therapies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intra Cellular Therapies often depends not only on the future outlook of the potential Intra-Cellular Therapies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intra-Cellular Therapies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 103.1 M | |
| Cash And Short Term Investments | 1 B |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Intra-Cellular Stock
If you are still planning to invest in Intra Cellular Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intra-Cellular Therapies' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |